Cite
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
MLA
N. Perrottet, et al. “Disposition of Valganciclovir during Continuous Renal Replacement Therapy in Two Lung Transplant Recipients.” Journal of Antimicrobial Chemotherapy (JAC), vol. 61, no. 6, June 2008, p. 1332. EBSCOhost, https://doi.org/10.1093/jac/dkn102.
APA
N. Perrottet, C. Robatel, P. Meylan, M. Pascual, J. P. Venetz, J. D. Aubert, M. M. Berger, L. A. Decosterd, & T. Buclin. (2008). Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients. Journal of Antimicrobial Chemotherapy (JAC), 61(6), 1332. https://doi.org/10.1093/jac/dkn102
Chicago
N. Perrottet, C. Robatel, P. Meylan, M. Pascual, J. P. Venetz, J. D. Aubert, M. M. Berger, L. A. Decosterd, and T. Buclin. 2008. “Disposition of Valganciclovir during Continuous Renal Replacement Therapy in Two Lung Transplant Recipients.” Journal of Antimicrobial Chemotherapy (JAC) 61 (6): 1332. doi:10.1093/jac/dkn102.